Author

Chenliang Qian

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID 0009-0009-6837-5320Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Organism:mouse· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Jie XiaiD· 2 shared Song WuiD· 2 shared Bochao YangiD· 1 shared Fan YangiD· 1 shared Hao WangiD· 1 shared Hongwei Jin· 1 shared Hongwei JiniD· 1 shared Liangren ZhangiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Jie XiaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyJournal of Pharmaceutical AnalysisPeer-reviewedOct 10, 2025

Geometry-based BERT: an experimentally validated deep learning model for molecular property prediction in drug discovery

Xiang Zhang, Chenliang Qian, Bochao Yang…·Liangren Zhang

This paper introduces GEO-BERT, a deep learning model for molecular property prediction, validated through benchmarking and prospective studies on DYRK1A inhibitors.

2 citations

deep learningdrug response / drug discovery

𝕏 PostBluesky

Pharmacology & ToxicologyInternational Journal of Biological MacromoleculesPeer-reviewedMay 2, 2024

Discovery of a Novel Chemotype as DYRK1A Inhibitors against Alzheimer's disease: Computational Modeling and Biological Evaluation

Nianzhuang Qiu, Chenliang Qian, Tingting Guo…·Jie Xia

This paper identifies a novel DYRK1A inhibitor, compound Q17, through computational screening and validates its efficacy in reducing AD-related pathology in vitro and in vivo.

8 citations

mouseproteomics

𝕏 PostBluesky